Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteria

RMD Open 2025;11:e005-444 DOI:10.1136/rmdopen-2025-005444


LinkedIn